MicroSintesis

Charlottetown, Canada Founded: 2011 • Age: 15 yrs
Provider of animal-based probiotic products to manage gut microbiome

About MicroSintesis

MicroSintesis is a company based in Charlottetown (Canada) founded in 2011.. MicroSintesis has raised $16.4 million across 1 funding round from investors including Northern Private Capital. MicroSintesis offers products and services including Nuvio Poultry. MicroSintesis operates in a competitive market with competitors including AnimalBiome, Biotangents, Cibus Biotechnologies, REVELAbiome and VETSCAN IMAGYST, among others.

  • Headquarter Charlottetown, Canada
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Microsintesis Inc
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $16.4 M (USD)

    in 1 rounds

  • Latest Funding Round
    $16.4 M (USD), Series B

    Jun 26, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MicroSintesis

MicroSintesis offers a comprehensive portfolio of products and services, including Nuvio Poultry. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Maintains intestinal balance in poultry by inhibiting harmful bacterial communication.

People of MicroSintesis
Headcount 10-50
Employee Profiles 7
Board Members and Advisors 1
Employee Profiles
People
Hannah McIver
CEO
People
Mohd Adil, PhD
Scientist
People
Alain Labbé
Research Director
People
Stephanie McNally
Laboratory Manager

Unlock access to complete

Funding Insights of MicroSintesis

MicroSintesis has successfully raised a total of $16.4M through 1 strategic funding round. The most recent funding activity was a Series B round of $16.4 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $16.4M
  • First Round

    (26 Jun 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2019 Amount Series B - MicroSintesis Valuation Northern Private Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MicroSintesis

MicroSintesis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Northern Private Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MicroSintesis

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MicroSintesis

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Microsintesis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MicroSintesis

MicroSintesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnimalBiome, Biotangents, Cibus Biotechnologies, REVELAbiome and VETSCAN IMAGYST, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Animal microbiome diagnostics services for pet care are offered.
domain founded_year HQ Location
Veterinary diagnostics products are developed for bovine viral diarrhea testing.
domain founded_year HQ Location
Diagnostic assays for animal disease detection are developed.
domain founded_year HQ Location
Serves as a digital test providing insights into the microbiome of cats and dogs.
domain founded_year HQ Location
Offers AI-powered diagnostic tools for veterinary clinics and professionals worldwide.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Microsintesis

Frequently Asked Questions about MicroSintesis

When was MicroSintesis founded?

MicroSintesis was founded in 2011 and raised its 1st funding round 8 years after it was founded.

Where is MicroSintesis located?

MicroSintesis is headquartered in Charlottetown, Canada. It is registered at Charlottetown, Prince Edward Island, Canada.

Who is the current CEO of MicroSintesis?

Hannah McIver is the current CEO of MicroSintesis.

Is MicroSintesis a funded company?

MicroSintesis is a funded company, having raised a total of $16.4M across 1 funding round to date. The company's 1st funding round was a Series B of $16.4M, raised on Jun 26, 2019.

What does MicroSintesis do?

MicroSintesis was founded in 2011 in Charlottetown, Canada, and operates in the animal health sector. Next-generation probiotic compounds are developed for dogs and swine to address gut health conditions. Products include Ygia for canines and Nuvia for swine, which target pathogenic bacterial functions to support digestive tract health. The focus remains on microbiome optimization for livestock and pets.

Who are the top competitors of MicroSintesis?

MicroSintesis's top competitors include Biotangents, AnimalBiome and Cibus Biotechnologies.

What products or services does MicroSintesis offer?

MicroSintesis offers Nuvio Poultry.

Who are MicroSintesis's investors?

MicroSintesis has 1 investor. Key investors include Northern Private Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available